RxSight Inc (RXST) with a beta value of 1.20 appears to be a promising investment opportunity.

RxSight Inc (NASDAQ: RXST) kicked off on Friday, down -5.92% from the previous trading day, before settling in for the closing price of $44.40. Over the past 52 weeks, RXST has traded in a range of $20.66-$66.54.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Healthcare Sector giant saw their annual sales surged by 201.89% over the last five years. While this was happening, its average annual earnings per share was recorded 42.73%. With a float of $36.96 million, this company’s outstanding shares have now reached $38.98 million.

The firm has a total of 374 workers. Let’s measure their productivity.

RxSight Inc (RXST) Breakdown of a Key Holders of the stock

Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of RxSight Inc is 5.19%, while institutional ownership is 80.05%. The most recent insider transaction that took place on Jul 01 ’24, was worth 586,055. In this transaction Chief Financial Officer of this company sold 10,000 shares at a rate of $58.61, taking the stock ownership to the 13,938 shares. Before that another transaction happened on Jul 01 ’24, when Company’s Chief Financial Officer sold 8,402 for $58.77, making the entire transaction worth $493,760. This insider now owns 0 shares in total.

RxSight Inc (RXST) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around 42.73% per share during the next fiscal year.

RxSight Inc (NASDAQ: RXST) Trading Performance Indicators

Take a look at RxSight Inc’s (RXST) current performance indicators. Last quarter, stock had a quick ratio of 8.18. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 16.10.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.25, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.49 in one year’s time.

Technical Analysis of RxSight Inc (RXST)

Analysing the last 5-days average volume posted by the [RxSight Inc, RXST], we can find that recorded value of 0.75 million was better than the volume posted last year of 0.48 million. As of the previous 9 days, the stock’s Stochastic %D was 23.84%. Additionally, its Average True Range was 2.71.

During the past 100 days, RxSight Inc’s (RXST) raw stochastic average was set at 3.01%, which indicates a significant decrease from 8.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 43.40% in the past 14 days, which was lower than the 48.25% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $54.01, while its 200-day Moving Average is $46.71. Now, the first resistance to watch is $42.78. This is followed by the second major resistance level at $43.78. The third major resistance level sits at $44.67. If the price goes on to break the first support level at $40.88, it is likely to go to the next support level at $39.99. Now, if the price goes above the second support level, the third support stands at $38.99.

RxSight Inc (NASDAQ: RXST) Key Stats

The company with the Market Capitalisation of 1.63 billion has total of 36,988K Shares Outstanding. Its annual sales at the moment are 89,080 K in contrast with the sum of -48,610 K annual income. Company’s last quarter sales were recorded 29,510 K and last quarter income was -9,100 K.